Evidence map›Paper›PMID 34669458›Full record

ArticleJournal of clinical microbiology2022

Management of Cytomegalovirus, Epstein-Barr Virus, and HIV Viral Load Quality Control Data Using Unity Real Time.

Duane W Newton, Nico Vandepoele, John C Yundt-Pacheco, David Gauthier, Michael A Bachman

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Duane W NewtonNaviDx Consulting, Mount Prospect, Illinois, USA.ORCID 0000-0002-9943-2449
Nico VandepoeleBio-Rad Laboratories, Irvine, California, USA.
John C Yundt-PachecoBio-Rad Laboratories, Irvine, California, USA.
David GauthierBio-Rad Laboratories, Irvine, California, USA.
Michael A BachmanDepartment of Pathology, Michigan Medicine, Ann Arbor, Michigan, USA.ORCID 0000-0003-2507-6987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quality control (QC) rules (Westgard rules) are applied to viral load testing to identify runs that should be reviewed or repeated, but this requires balancing the patient safety benefits of error detection with the cost and inefficiency of false rejection. In this study, we identified the total allowable errors (TEa) from the literature and utilized a commercially available software program (Unity Real Time; Bio-Rad Laboratories) to manage QC data, assess assay performance, and provide QC decision support for both FDA-approved/cleared (Abbott cytomegalovirus [CMV] and HIV viral load) as well as laboratory-developed (Epstein-Barr virus [EBV] viral load) assays. Unity Real Time was used to calculate means, standard deviations (SDs), and coefficient of variation (CV; in percent) of negative, low-positive, and high-positive control data from 73 to 83 days of testing. Sigma values were calculated to measure the test performance relative to a TEa of 0.5 log

Indexed as

Epstein-Barr Virus InfectionsHIV InfectionsCytomegalovirusDNA, ViralHerpesvirus 4, HumanHumansQuality ControlViral LoadDNA, Viralquality controlquality data managementtotal allowable errorviral load

Identifiers

PMID34669458
PMCPMC8769726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.